Astellas Pharma, Inc. - Company & Market Research Reports

Home /
Companies /
Astellas Pharma, Inc.

Astellas formed in 2005 through the merger of Yamanouchi and Fujisawa. The company employs over 400 people in Ireland across three locations. It has successfully launched innovative products and established itself as a category leader in the therapeutic areas of Transplantation and Urology. Astellas Pharma is one of the world’s top 20 pharmaceutical companies, employing 15,000 people globally. Its headquartered at the Citywest Business Campus in Dublin 24.

REFINE BY

KEYWORD

CATEGORIES

Oncology Drugs 118
Infectious Diseases Drugs 93
Endocrine and Metabolic Disorders Drugs 74
Central Nervous System Drugs 65
Genomics 59
Immune Disorders Drugs 57
Drug Discovery 47
Pharmaceuticals 44
Diabetes Drugs 42
Prostate Cancer Drugs 42
Vaccines 40
Biopharmaceuticals 39
Clinical Trials 37
Urological Disorders Drugs 35
Dermatological Drugs 33
Women's Health 32
Enzymes 30
Gastrointestinal Drugs 29
Biotechnology 28
Musculoskeletal Disorders Drugs 28
Cardiovascular Drugs 26
Liver and Kidney Disorders Drugs 26
Leukemia Drugs 25
Immunosuppressive Drugs 23
Antibiotics 21
Sexual and Reproductive Health Drugs 21
Optical Disorders Drugs 20
Allergy and Immunology 20
Surgical Procedures 20
Stem Cells 19
Analgesics 17
Oncology 17
Optical 14
Urology and Nephrology 13
Bladder Cancer Drugs 13
Infusions and Injectables 13
Diagnostics 13
Lung Cancer Drugs 12
Medical Devices 12
Drug Delivery 12
Dermatology 11
Pharmaceutical Manufacturing 10
Healthcare Services 9
Respiratory Drugs 9
Therapeutic Area 8
Neurology 8
Pulmonary Medicine 7
Lymphoma Drugs 7
Hearing Aids and Implants 7
Mental Disorders Drugs 7
Kidney Cancer Drugs 7
Gastroenterology 7
Pharmaceutical Intermediates 6
Biomaterials 6
Needles and Syringes 6
Hematology 6
Over the Counter (OTC) Drugs 6
Proteomics 5
Managed Care 5
Hematological Drugs 5
Allergy Drugs 5
Brain Cancer Drugs 4
Cardiovascular Devices 4
Infectious Disease Testing 4
Cancer Vaccines 4
Pancreatic Cancer Drugs 4
Pediatrics 4
Company Reports 3
Drugs by Therapeutic Area 3
Colon Cancer Drugs 3
In Vitro Diagnostics 3
Mental Health 3
Skin Cancer Drugs 3
Schizophrenia Drugs 3
Liver Cancer Drugs 2
Breast Cancer Drugs 2
Ovarian Cancer Drugs 2
Medical Imaging 2
Glucose Testing 2
Cough and Cold Drugs 2
Diabetes Devices 2
Transdermal and Transmucosal Drug Delivery 2
Biomarkers 2
Surgical Devices 2
Thyroid Cancer Drugs 2
Laboratory Equipment 2
Cardiology 2
Asthma Drugs 2
Addiction Disorders Drugs 1
Patient Monitoring Equipment 1
E-Healthcare 1
Pharmacoeconomics 1
Fertility Services 1
Bioinformatics 1
Dialysis 1
Healthcare 1
Dental 1
Hospital Management 1
Alternative and Complementary Medicine 1
Molecular Diagnostics 1
Contrast Media 1
Nuclear Medicine and Radiopharmacology 1
Biosimilars and Biosuperiors 1
Nanomedicine 1
Anti-Obesity Drugs 1
Palliative Care 1
Anatomy 1
Acne Drugs 1
Alzheimer's Disease Drugs 1

SHOW ALL

REPORT TYPE

All Reports

Company Reports

Market Reports

Google Reviews

4.8



281 reviews

1,144 Results (Page 37 of 58)
- Relevance
  Sort by

Stomach Cancer Treatment Market - Global Strategic Business Report

 Report
December 2025
371 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Cancer Antibody Drug Conjugates Market - Global Strategic Business Report

 Report
December 2025
482 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Metastatic Cancer Drugs Market - Global Strategic Business Report

 Report
December 2025
377 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

Rotavirus Prophylaxis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3958EUR$4,490USD£3,477GBP

Antibody Drug Conjugates (ADC) - Global Strategic Business Report

 Report
December 2025
193 Pages
Global

From

€5157EUR$5,850USD£4,530GBP

NEED HELP FINDING THE RIGHT PRODUCT? Brian will help you find what you are looking for.

Call: 1-800-526-8630 ASK A QUESTION REQUEST A CALL BACK

Onychomycosis Treatment Market 2024-2028

 Report
August 2024
168 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Translational Regenerative Medicine Market - Global Forecast 2025-2032

 Report
November 2025
190 Pages
Global

From

€3125EUR$3,545USD£2,745GBP

€3473EUR$3,939USD£3,050GBP

Cancer Immunotherapy Market Size, Share & Trends Analysis Report by Product, Application, Distribution (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End-use, with Growth Forecasts, 2025-2030

 Report
April 2025
110 Pages
Global

From

€5246EUR$5,950USD£4,607GBP

Antibody Therapeutics Market - Global Forecast 2025-2030

 Report
November 2025
188 Pages
Global

From

€3125EUR$3,545USD£2,745GBP

€3473EUR$3,939USD£3,050GBP

Regenerative Medicine Market - Global Forecast 2025-2032

 Report
November 2025
195 Pages
Global

From

€3125EUR$3,545USD£2,745GBP

€3473EUR$3,939USD£3,050GBP

Alpha Glucosidase Inhibitors Market - Global Forecast 2025-2032

 Report
November 2025
189 Pages
Global

From

€3125EUR$3,545USD£2,745GBP

€3473EUR$3,939USD£3,050GBP

Investor Series: Opportunities in the Artificial Intelligence in Drug Discovery Market

 Report
December 2022
142 Pages
Global

From

€1674EUR$1,899USD£1,470GBP

Antiemetics and Antinauseants Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3958EUR$4,490USD£3,477GBP

Antibody Drug Conjugates Market Size, Share & Trends Analysis Report By Application (Blood Cancer, Breast Cancer), By Technology (Type-cleavable, Non-cleavable), By Product, By Target, By Region, And Segment Forecasts, 2024 - 2030

 Report
April 2024
125 Pages
Global

From

€5246EUR$5,950USD£4,607GBP

3-Kinase Delta Syndrome Market - Global Forecast 2025-2032

 Report
November 2025
183 Pages
Global

From

€3125EUR$3,545USD£2,745GBP

€3473EUR$3,939USD£3,050GBP

Primary Immunodeficiency Therapeutics Market 2024-2028

 Report
July 2024
136 Pages
Global

From

€2204EUR$2,500USD£1,936GBP

Gastroesophageal Reflux Disease Therapeutics Market Report 2025

 Report
September 2025
250 Pages
Global

From

€3958EUR$4,490USD£3,477GBP

Covid-19 Vaccine Market - Analysis By Product Type, Patient Type, End User, By Region, By Country (2021 Edition): Market Insights, Competition and Forecast (2020-2030)

 Report
March 2021
214 Pages
Global

From

€1763EUR$2,000USD£1,549GBP

Idiopathic Thrombocytopenic Purpura - Pipeline Insight, 2025

 Clinical Trials
April 2025
60 Pages
Global

From

€1411EUR$1,600USD£1,239GBP

€1763EUR$2,000USD£1,549GBP

Osteoarthritis Market Report 2025

 Report
March 2025
200 Pages
Global

From

€3958EUR$4,490USD£3,477GBP

1,144 Results (Page 37 of 58)
- 1
- 35
- 36
- 37
- 38
- 39

ASK A QUESTION

An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net

*Required Information

Name*

Email Address* Please provide your business or academic email address.

Country*

Phone Number*

Your Question*

I have read Research and Markets' Privacy Policy and consent to the processing of my personal data.

We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.